242 related articles for article (PubMed ID: 15019073)
1. Stomach-specific anti-H. pylori therapy; part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils.
Hejazi R; Amiji M
Int J Pharm; 2004 Mar; 272(1-2):99-108. PubMed ID: 15019073
[TBL] [Abstract][Full Text] [Related]
2. Stomach-specific anti-H. pylori therapy. II. Gastric residence studies of tetracycline-loaded chitosan microspheres in gerbils.
Hejazi R; Amiji M
Pharm Dev Technol; 2003 Aug; 8(3):253-62. PubMed ID: 12901691
[TBL] [Abstract][Full Text] [Related]
3. Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres.
Hejazi R; Amiji M
Int J Pharm; 2002 Mar; 235(1-2):87-94. PubMed ID: 11879743
[TBL] [Abstract][Full Text] [Related]
4. Toxicity and gut associated lymphoid tissue translocation of polymyxin B orally administered by alginate/chitosan microparticles in rats.
Coppi G; Bondi M; Coppi A; Rossi T; Sergi S; Iannuccelli V
J Pharm Pharmacol; 2008 Jan; 60(1):21-6. PubMed ID: 18088501
[TBL] [Abstract][Full Text] [Related]
5. Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application.
Fernandes M; Gonçalves IC; Nardecchia S; Amaral IF; Barbosa MA; Martins MC
Int J Pharm; 2013 Sep; 454(1):116-24. PubMed ID: 23850814
[TBL] [Abstract][Full Text] [Related]
6. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori.
Umamaheshwari RB; Jain S; Bhadra D; Jain NK
J Pharm Pharmacol; 2003 Dec; 55(12):1607-13. PubMed ID: 14738585
[TBL] [Abstract][Full Text] [Related]
7. Chitosan microparticle preparation for controlled drug release by response surface methodology.
Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
[TBL] [Abstract][Full Text] [Related]
8. Formulation and in vitro characterization of spray dried microspheres of amoxicillin.
Raval JA; Patel JK; Patel MM
Acta Pharm; 2010 Dec; 60(4):455-65. PubMed ID: 21169137
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties.
Lin WC; Yu DG; Yang MC
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):143-51. PubMed ID: 16054345
[TBL] [Abstract][Full Text] [Related]
10. Effects of indomethacin and rofecoxib on gastric mucosal damage in normal and Helicobacter pylori-infected mongolian gerbils.
Kanatani K; Ebata M; Murakami M; Okabe S
J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):207-22. PubMed ID: 15082879
[TBL] [Abstract][Full Text] [Related]
11. Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent.
Kumbar SG; Kulkarni AR; Aminabhavi M
J Microencapsul; 2002; 19(2):173-80. PubMed ID: 11837972
[TBL] [Abstract][Full Text] [Related]
12. Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.
Gupta KC; Jabrail FH
Carbohydr Res; 2006 May; 341(6):744-56. PubMed ID: 16499893
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
Akbuğa J; Bergişadi N
J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
[TBL] [Abstract][Full Text] [Related]
14. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle.
Ozbas-Turan S; Aral C; Kabasakal L; Keyer-Uysal M; Akbuga J
J Pharm Pharm Sci; 2003; 6(1):27-32. PubMed ID: 12753728
[TBL] [Abstract][Full Text] [Related]
15. Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies.
Ventura CA; Tommasini S; Crupi E; Giannone I; Cardile V; Musumeci T; Puglisi G
Eur J Pharm Biopharm; 2008 Feb; 68(2):235-44. PubMed ID: 17614266
[TBL] [Abstract][Full Text] [Related]
16. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres.
Govender S; Pillay V; Chetty DJ; Essack SY; Dangor CM; Govender T
Int J Pharm; 2005 Dec; 306(1-2):24-40. PubMed ID: 16246512
[TBL] [Abstract][Full Text] [Related]
17. Bioprocess of uniform-sized crosslinked chitosan microspheres in rats following oral administration.
Wei W; Wang LY; Yuan L; Yang XD; Su ZG; Ma GH
Eur J Pharm Biopharm; 2008 Aug; 69(3):878-86. PubMed ID: 18417329
[TBL] [Abstract][Full Text] [Related]
18. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
Wang LY; Gu YH; Su ZG; Ma GH
Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
[TBL] [Abstract][Full Text] [Related]
19. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
20. Stomach specific anti-helicobacter pylori therapy: preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres.
Patel JK; Patel MM
Curr Drug Deliv; 2007 Jan; 4(1):41-50. PubMed ID: 17269916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
